Substituted propanamides as inhibitors of nucleases

• Authors: PARUCH Kamil; CARBAIN Benoit Jean-Pierre; HAVEL Štěpán; VŠIANSKÝ Vít; NIKULENKOV Fedor; KREJČÍ Lumír
• Year of publication: 2022
• Type: Patent
• MU Faculty or unit: Faculty of Science
• Publisher: United States Patent and Trademark Office
• State: United States of America
• Patent's number: US11453663
• Web: https://worldwide.espacenet.com/patent/search?q=pn%3DUS11453663B2
• Description: Compounds represented by the structural formula (1) where R1, R2, R3, R4, R5, R6 are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.

Related projects

• Preclinical Progression of New Organic Compounds with Targeted Biological Activity
• CZ-­OPENSCREEN: National Infrastructure for Chemical Biology